A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
DualityBio Inc.
Lumicell, Inc.
M.D. Anderson Cancer Center
BicycleTx Limited
Revolution Medicines, Inc.
Bolt Biotherapeutics, Inc.
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.
Mirror Biologics, Inc.
FeRx